CV Sciences, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
CVSIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30,2025 | December 31,2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash | $381 | $454 |
| Accounts receivable, net | 405 | 522 |
| Inventory | 4,080 | 4,897 |
| Prepaid expenses and other | 231 | 370 |
| Total current assets | 5,097 | 6,243 |
| Property and equipment, net | 349 | 399 |
| Right of use assets | 410 | 94 |
| Intangibles, net | 82 | 93 |
| Goodwill | 1,010 | 971 |
| Other assets | 47 | 127 |
| Total assets | $6,995 | $7,927 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,214 | $1,925 |
| Accrued expenses | 2,874 | 3,424 |
| Current portion of operating lease liability | 247 | 83 |
| Current portion of long-term debt, net of debt issuance costs | 451 | 677 |
| Total current liabilities | 4,786 | 6,109 |
| Operating lease liability | 162 | 19 |
| Debt, net of debt issuance costs | 504 | — |
| Deferred tax liability | 4 | 4 |
| Total liabilities | 5,456 | 6,132 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity | ||
| Preferred stock, par value $0.0001; 10,000 shares authorized; 1 share issued as of September 30, 2025 and December 31, 2024; and no shares outstanding as of September 30, 2025 and December 31, 2024 | — | — |
| Common stock, par value $0.0001; 790,000 shares authorized as of September 30, 2025 and December 31, 2024; 184,264 shares issued and outstanding as of September 30, 2025 and December 31, 2024 | 18 | 18 |
| Additional paid-in capital | 89,207 | 88,773 |
| Accumulated deficit | (87,733) | (86,981) |
| Accumulated other comprehensive income (loss) | 47 | (15) |
| Total stockholders' equity | 1,539 | 1,795 |
| Total liabilities and stockholders' equity | $6,995 | $7,927 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.